Photofunctionalization With UVC

Not Applicable

Recruiting

• Conditions: Implant Site Reaction

• Registration Number: NCT06724107
• Lead Sponsor: Universidad Complutense de Madrid

Brief Summary

Summary:

Objective: The general objective is to compare the placement of standard implants with a surface photofunctionalization technique based on ultraviolet C radiation (UVC), having as working hypothesis that this photofunctionalization will accelerate the bone apposition on the implant surface and increase the amount of bone that binds to the implant, making it possible to load these photofunctionalized implants in less time.

Design: Pilot, clinical, randomized, prospective, controlled, single-center, prospective study.

Scope of the study: Master's Degree in Oral Surgery and Implantology. Faculty of Dentistry. Complutense University of Madrid.

Subjects of the study: patients attending the Master's Degree in Oral Surgery and Implantology for rehabilitation with dental implants, regardless of the sector in which they have missing teeth.

Key words: ISQ (implant stability quotient), inmediate loading, UVC, dental implants.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-09-22
• Status Verified: 2024-11
• Study First Submitted QC: 2024-12-06
• Last Update Submitted: 2024-12-06
• Study First Posted: 2024-12-09
• Last Update Posted: 2024-12-09
• Study Start: 2024-12-12
• Primary Completion: 2025-06-20
• Study Completion: 2026-04-20

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patients over 18 years of age.
• Patients requiring dental implant surgery with or without bone or soft tissue regeneration surgery.
• Acceptance of the informed consent document.

Exclusion Criteria

• Subjects with systemic diseases leading to untreated or uncontrolled haemostasis or coagulation disturbances.
• Subjects with active infectious diseases (tuberculosis, HIV, syphilis, hepatitis, etc).
• Patients under pharmacological treatment with monoclonal antibodies, bisphosphonates, chemotherapy or prolonged treatment with corticoids.
• Patients with alcoholism or drug addiction.
• Pregnant or breastfeeding women.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Bone regeneration	3 months	Bone implant contact (BIC) Histotogic parameter in percentage

Secondary Outcome Measures

Name	Time	Method
ISQ and marginal bone loss	12 months	Implant stability quotient and marginal bone loss measure with X-rays (quantitative parameter)

Trial Locations

Locations (1)

Jesus Torres; 🇪🇸 Madrid, Spain